{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 461097524
| IUPAC_name = (8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-<br />2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-<br />1H-cyclopenta[a]phenanthren-17-ol
| image = Ethylestrenol.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|ethylestrenol}}
| pregnancy_category =  
| legal_CA = Schedule IV
| legal_US = Schedule III
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  

<!--Identifiers-->
| IUPHAR_ligand = 6948
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 965-90-2
| ATC_prefix = A14
| ATC_suffix = AB02
| PubChem = 13765
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01493
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13168
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = ADC79EK5Q8
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01414
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31578
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200623

<!--Chemical data-->
| C=20 | H=32 | O=1 
| molecular_weight = 288.467 g/mol
| smiles = O[C@]2(CC[C@H]1[C@H]4[C@H](CC[C@@]12C)[C@@H]3\C(=C/CCC3)CC4)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AOXRBFRFYPMWLR-XGXHKTLJSA-N
}}

'''Ethylestrenol''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]], [[British Approved Name|BAN]]) (brand names '''Maxibolin''', '''Orabolin'''), or '''ethylnandrol''' ([[Japanese Accepted Name|JAN]]), also known as '''17α-ethylestr-4-en-17β-ol''' or as '''3-deketo-17α-ethyl-19-nortestosterone''', is an [[anabolic-androgenic steroid]] (AAS) with some [[progestogen]]ic activity, and low [[androgen]]ic activity.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA168|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=518–519}}</ref> It is a [[17α-alkylated AAS|17α-ethylated]] [[chemical derivative|derivative]] of [[nandrolone]] and lacks the 3-keto group. It was described in the literature in 1959<ref name="Elks2014" /> and approved in 1964 for [[testosterone deficiency]] in male patients.<ref>http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20791_TESTODEM%20TTS%205MG%20PER%20DAY_MEDR.PDF</ref>

==See also==
* [[Nandrolone]] (estra-4-en-17β-ol-3-one)
* [[Ethisterone]] (17α-ethynylandrost-4-en-17β-ol-3-one)
* [[Norethisterone]] (17α-ethynylestra-4-en-17β-ol-3-one)
* [[Allylestrenol]] (the 17α-allyl variant of ethylestrenol)

==References==
{{Reflist|2}}


{{Androgens and antiandrogens}}
{{Progestogens and antiprogestogens}}
{{Androgen receptor modulators}}
{{Progesterone receptor modulators}}

[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Hepatotoxins]]
[[Category:Progestogens]]
[[Category:World Anti-Doping Agency prohibited substances]]
[[Category:Alkene derivatives]]


{{steroid-stub}}
{{genito-urinary-drug-stub}}